Investigating the potential added value of [18F]FDG-PET/CT in long COVID patients with persistent symptoms: a proof of concept study
Description
CONCLUSION: As we found no quantitative difference in the TBR or TVS between long COVID patients and controls, we are unable to prove that [18F]FDG is of added value for long COVID patients with symptoms of myalgia or joint pain. Prospective cohort